PortfoliosLab logo

CymaBay Therapeutics, Inc. (CBAY)

Equity · Currency in USD · Last updated May 21, 2022

Company Info

Trading Data

  • Previous Close$2.10
  • Year Range$1.72 - $4.92
  • EMA (50)$2.52
  • EMA (200)$3.31
  • Average Volume$567.56K
  • Market Capitalization$160.89M

CBAYShare Price Chart


Chart placeholderClick Calculate to get results

CBAYPerformance

The chart shows the growth of $10,000 invested in CymaBay Therapeutics, Inc. on Feb 3, 2014 and compares it to the S&P 500 index or another benchmark. It would be worth nearly $2,333 for a total return of roughly -76.67%. All prices are adjusted for splits and dividends.


CBAY (CymaBay Therapeutics, Inc.)
Benchmark (^GSPC)

CBAYReturns in periods

Returns over 1 year are annualized

PeriodReturnBenchmark
1M-30.00%-12.57%
YTD-37.87%-18.14%
6M-47.10%-17.07%
1Y-51.05%-5.21%
5Y-11.69%10.37%
10Y-16.64%8.99%

CBAYMonthly Returns Heatmap


Chart placeholderClick Calculate to get results

CBAYSharpe Ratio Chart

The Sharpe ratio shows whether the portfolio's excess returns are due to smart investment decisions or a result of taking a higher risk. The higher a portfolio's Sharpe ratio, the better its risk-adjusted performance.

The current CymaBay Therapeutics, Inc. Sharpe ratio is -0.94. A negative Sharpe ratio means that the risk-free rate is higher than the portfolio's return. This value does not convey any meaningful information.

The chart below displays rolling 12-month Sharpe Ratio.


CBAY (CymaBay Therapeutics, Inc.)
Benchmark (^GSPC)

CBAYDividend History


CymaBay Therapeutics, Inc. doesn't pay dividends

CBAYDrawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way.


CBAY (CymaBay Therapeutics, Inc.)
Benchmark (^GSPC)

CBAYWorst Drawdowns

The table below shows the maximum drawdowns of the CymaBay Therapeutics, Inc.. A maximum drawdown is an indicator of risk. It shows a reduction in portfolio value from its maximum due to a series of losing trades.

The maximum drawdown since January 2010 for the CymaBay Therapeutics, Inc. is 92.85%, recorded on Feb 11, 2016. It took 505 trading sessions for the portfolio to recover.


Depth

Start

To Bottom

Bottom

To Recover

End

Total

-92.85%Feb 19, 2015248Feb 11, 2016505Feb 13, 2018753
-91.75%Mar 5, 2018514Mar 18, 2020
-44.44%Mar 5, 201460Aug 21, 201485Dec 22, 2014145
-10.19%Jan 9, 20159Jan 22, 20157Feb 2, 201516
-4.41%Feb 21, 20187Mar 1, 20181Mar 2, 20188
-3.17%Feb 10, 20152Feb 11, 20153Feb 17, 20155
-3%Dec 23, 20141Dec 23, 20142Dec 26, 20143
-1.73%Jan 2, 20152Jan 5, 20151Jan 6, 20153
-0.3%Feb 14, 20181Feb 14, 20181Feb 15, 20182

CBAYVolatility Chart

Current CymaBay Therapeutics, Inc. volatility is 83.45%. The chart below shows the rolling 10-day volatility. Volatility is a statistical measure showing how big price swings are in either direction. The higher asset volatility, the riskier it is, because the price movements are less predictable.


CBAY (CymaBay Therapeutics, Inc.)
Benchmark (^GSPC)

Portfolios with CymaBay Therapeutics, Inc.


Loading data...

More Tools for CymaBay Therapeutics, Inc.